CXCR4+ mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis

Tumor-initiating cells (TICs) share features and regulatory pathways with normal stem cells, yet how the stem cell niche contributes to tumorigenesis remains unclear. Here, we identify CXCR4<sup>+</sup> macrophages as a niche population enriched in normal mammary ducts, where they promote the regenerative activity of basal cells in response to luminal cell-derived CXCL12. CXCL12 triggers AKT-mediated stabilization of β-catenin, which induces Wnt ligands and pro-migratory genes, enabling intraductal macrophage infiltration and supporting regenerative activity of basal cells. Notably, these same CXCR4<sup>+</sup> niche macrophages regulate the tumor-initiating activity of various breast cancer subtypes by enhancing TIC survival and tumor-forming capacity, while promoting early immune evasion through regulatory T cell induction. Furthermore, a CXCR4<sup>+</sup> niche macrophage gene signature correlates with poor prognosis in human breast cancer. These findings highlight the pivotal role of the CXCL12-CXCR4 axis in orchestrating interactions between niche macrophages, mammary epithelial cells, and immune cells, thereby establishing a supportive niche for both normal tissue regeneration and mammary tumor initiation.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-05-25
DOI
https://doi.org/10.1038/s41467-025-59972-z
Citations
11
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
8.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CXCR4+ mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis

Natalie Sauerwald, Chandra L. Theesfeld, Geoffrey Vargas, Jean Arly Volmar et al.
11 citations
Nature Communications
Immunotherapy and Immune Responses
8.77
article

CXCR4+ mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis

Natalie Sauerwald, Chandra L. Theesfeld, Geoffrey Vargas, Jean Arly Volmar, Christina J. DeCoste, Gary Laevsky, Yibin Kang, Yong Wei, Jennifer Miller, Wei Wang, Sha Wang, Eun-Mi Lee, Jason J Hong, Xiang Hang
article en
11 citations

Abstract

Tumor-initiating cells (TICs) share features and regulatory pathways with normal stem cells, yet how the stem cell niche contributes to tumorigenesis remains unclear. Here, we identify CXCR4<sup>+</sup> macrophages as a niche population enriched in normal mammary ducts, where they promote the regenerative activity of basal cells in response to luminal cell-derived CXCL12. CXCL12 triggers AKT-mediated stabilization of β-catenin, which induces Wnt ligands and pro-migratory genes, enabling intraductal macrophage infiltration and supporting regenerative activity of basal cells. Notably, these same CXCR4<sup>+</sup> niche macrophages regulate the tumor-initiating activity of various breast cancer subtypes by enhancing TIC survival and tumor-forming capacity, while promoting early immune evasion through regulatory T cell induction. Furthermore, a CXCR4<sup>+</sup> niche macrophage gene signature correlates with poor prognosis in human breast cancer. These findings highlight the pivotal role of the CXCL12-CXCR4 axis in orchestrating interactions between niche macrophages, mammary epithelial cells, and immune cells, thereby establishing a supportive niche for both normal tissue regeneration and mammary tumor initiation.

Nature CommunicationsVol. 16(1)
Rutgers, The State University of New Jersey (US), Princeton University (US), Ludwig Cancer Research (US), Flatiron Health (United States) (US), Flatiron Institute (US)
U.S. Department of Defense, American Cancer Society, Susan G. Komen for the Cure, Breast Cancer Research Foundation, Princeton University, Rutgers Cancer Institute of New Jersey, Brewster Foundation, Susan G. Komen, Ludwig Institute for Cancer Research, National Institutes of Health, National Cancer Institute
Openalex Percentile: Top 2%
Immunotherapy and Immune Responses
8.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.